Reglan Lawyers: Tardive Dyskinesia Lawsuits

Reglan Lawsuits

The FDA has issued a black box warning for Reglan (generic: metoclopramide), which states that the acid reflux drug can lead to tardive dyskinesia. This neurological disorder causes involuntary movements of the face and extremities and in severe cases may cause difficulty breathing. Unfortunately, there is no treatment for tardive dyskinesia.

If you or a loved one has developed tardive dyskinesia as a side effect of Reglan or the generic equivalent metoclopramide, fill out our free, no risk case evaluation form.

To date, no Reglan class action lawsuits have been filed, but those who have suffered from tardive dyskinesia have filed individual Reglan claims. Many Reglan lawsuits have claimed that metoclopramide drug manufacturers were negligent in developing these drugs. For example, Reglan lawsuits have asserted that these manufacturers had knowledge that long-term use of Reglan was not safe. Other Reglan lawsuits claimed that the pharmaceutical companies knew that patients taking Reglan for more than 12 weeks had a risk of developing tardive dyskinesia that was 100 times greater than disclosed in packaging inserts. Other Reglan lawsuits have claimed that the manufacturers:

• Failed to investigate the accuracy of Reglan's label once safety became an issue
• Did not monitor all relevant scientific information related to the drug
• Failed to conduct post market safety surveillance
• Knew the potential risks of Reglan outweighed the drug's benefits

Our Reglan lawyers are dedicated to ensuring that pharmaceutical companies are responsible for the side effects of their drugs. If you or a loved one has developed tardive dyskinesia from using Reglan or the generic metoclopramide, contact our skilled Reglan attorneys today.